Article thumbnail

Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: a pilot study

By B Formby and F Schmidt
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3068872
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A web of circadian pacemakers.
  2. (2008). Advances in hormone replacement therapy: making menopause manageable. BMC Women’s Health.
  3. Connections and regulation of the human estrogen receptor.
  4. Contemporary therapy of the menopausal syndrome.
  5. Effects of 17beta-estradiol on neuronal cell excitability and neurotransmission in the suprechiasmatic nucleus of rat.
  6. (2001). Molecular analysis of mammalian circadian rhythms. Ann Rev Physiol.
  7. (2010). Natural hormone therapy for menopause. Gynecol Endocrinol.
  8. (2008). Period-2: a tumor suppressor gene in breast cancer. J Cir Rhythms.
  9. Salivary sex hormones during menstrual cycle.
  10. Sex hormone receptors are present in the human supra-chiasmatic nucleus.
  11. (2009). The bioidentical hormone debate. Postgrad Med.
  12. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.
  13. The clock gene Per2 links the circadion system to the estrogen receptor.
  14. (2003). The mammalian circadian clock. Curr Opin Genet Dev.
  15. (2007). The role of circadian regulation in cancer. Cold Habor Symp Quantiv Biol.
  16. Transdermal menopausal hormone therapy: delivery through the skin changes the rules. Expert Opin Pharmacother.
  17. Up-regulation of Per1 expression by estradiol and progesterone in the rat uterus.